As a leader in Booz Allen’s civil health business, Roman Salasznyk is passionate about working with federal health agencies to deliver enabling technologies and strategies aimed to accelerate research and deliver better health outcomes.
This past year, his team worked with the Food and Drug Administration, the National Institutes of Health, the Biomedical Advanced Research and Development Authority and across the military health ecosystem to play a critical role in the nation’s response to COVID-19. His team delivered leading-edge solutions focused on expediting medical product approvals, fostering biomedical innovation and improving mission performance.
“In a time where health care is undergoing a tremendous period of change marked by innovation and transformation, bridging the rapid advances between science, technology and artificial intelligence is paramount to driving scientific breakthroughs, developing personalized therapeutic treatments and protecting supply chains across a global network,” Salasznyk said. “Booz Allen empowers its staff to be bold and have an everlasting impact at the core of our clients’ mission-critical work and these public health priorities.”
Salasznyk leads Booz Allen’s life science business and provides support across multiple agencies in the Department of Health and Human Services. In these roles, he works with a team of technologists, informaticians and life science practitioners focused on delivering enterprise-ready capabilities supporting their clients’ IT/data modernization and business needs. Salasznyk said he is committed to supporting transformational change to support Booz Allen’s federal health clients well into the future.